Organocatalytic Stereoselective Synthesis of 3-Alkyl-3-hydroxy-2-oxindoles
1
7.28-7.47 (m, 7H), 6.57 (d, J=8.4 Hz, 1H), 4.95 (d,
J=16.0 Hz, 1H), 4.83 (d, J=15.6 Hz, 1H), 3.02-3.07
(m, 1H), 2.51 (d, J=15.2 Hz, 1H), 2.31-2.39 (m, 1H),
2.08 (d, J=14.8 Hz, 2H), 1.94 (s, 1H), 1.62-1.72 (m,
3H); 13C NMR (100 MHz, CDCl3) δ: 214.0, 211.3,
176.6, 174.5, 142.7, 142.1, 135.1, 134.9, 132.5, 132.4,
131.7, 130.9, 128.9, 128.8, 128.7, 127.9, 127.8, 127.5,
127.3, 116.1, 115.6, 111.1, 55.8, 55.7, 44.0, 42.6, 42.0,
28.2, 27.2, 26.8, 26.2, 24.6, 24.3; HRMS (ESI) calcd for
C21H20BrNO3 (M+H+) 414.0699, found 414.0696.
HPLC separation conditions: Chiralcel AD-H, solvent:
Hexane/i-PrOH, V ∶V =80 ∶20, flow rate =1.0
mL/min, λ=254 nm. Retention time: tR(anti,major)=
56.36 min and tR(anti,minor)=66.83 min.
Entry 1):[11] [α]1D7 +2.20 (c 0.10, CHCl3, 5% ee); H
NMR (400 MHz, DMSO-d6) δ: 10.19 (s, 1H), 7.24-
7.15 (m, 2H), 6.92-6.88 (m, 1H ), 6.77 (d, J=7.6 Hz,
1H), 5.95 (s, 1H), 3.26 (d, J=16.4 Hz, 1H), 2.99 (d, J=
16.4 Hz, 1H), 2.00 (s, 3H). HPLC separation conditions:
Chiralcel OJ-H, solvent: Hexane/i-PrOH, V∶V=80∶
20, flow rate=1.0 mL/min, λ=254 nm. Retention time:
tR(major)=28.11 min and tR(minor)=41.98 min.
3-Hydroxy-3-(2-oxocyclopentyl)indolin-2-one (Table
6, Entry 2):[23] [α]1D7 +31.33 (c 0.10, CHCl3, 26% ee);
1H NMR (400 MHz, DMSO-d6) δ: 10.30 (s, 1H), 7.36
(d, J=7.2 Hz, 1H), 7.18 (t, J=7.6 Hz, 1H), 6.89 (t, J=
7.6 Hz, 1H), 5.99 (s, 1H), 2.88 (t, J=10.0 Hz, 1H),
2.22 -1.72 (m, 6H). HPLC separation conditions:
Chiralcel AD-H, solvent: Hexane/i-PrOH, V∶V=90∶
10, flow rate=1.0 mL/min, λ=254 nm. Retention time:
tR(major)=40.32 min and tR(anti,minor)=44.76 min.
3-Hydroxy-3-(4-oxotetrahydro-2H-pyran-3-yl)indo-
lin-2-one (Table 6, Etry 3):[37] [α]1D7 −26.0 (c 0.10,
(R)-1-Benzyl-3-hydroxy-5-methyl-3-((S)-2-oxocyclo-
hexyl)indolin-2-one (Table 5, Entry 10): [α]1D7 −14.7 (c
1
0.20, CHCl3, 86% ee); H NMR (400 MHz, CDCl3) δ:
7.28-7.34 (m, 5H), 7.18 (s, 1H), 7.01 (d, J=8.0 Hz,
1H), 6.58 (d, J=8.0 Hz, 1H), 5.01 (br s, 1H), 4.96 (d,
J=16.0 Hz, 1H), 4.82 (d, J=16.0 Hz, 1H), 3.00-3.05
(m, 1H), 2.52 (d, J=15.2 Hz, 1H), 2.34-2.39 (m, 1H),
2.04 (br s, 1H), 1.90 (s, 1H), 1.57-1.73 (m, 4H); 13C
NMR (100 MHz, CDCl3) δ: 211.9, 211.8, 177.0, 176.9,
175.0, 141.2, 135.7, 132.5, 130.0, 128.9, 128.8, 128.7,
127.5, 124.9, 109.3, 55.7, 55.4, 53.5, 43.9, 42.7, 42.1,
28.3, 27.2, 26.8, 26.1, 24.5, 24.3, 21.2, 21.1; HRMS
(ESI) calcd for C22H24NO3 (M+H+) 350,1750, found
350.1743. HPLC separation conditions: Chiralcel AD,
solvent: Hexane/i-PrOH, V∶V=80∶20, flow rate=
1.0 mL/min, λ=254 nm. Retention time: tR(anti,major)=
29.08 min and tR(anti,minor)=25.02 min.
1
CHCl3, 21% ee); H NMR (400 MHz, DMSO-d6) δ:
10.30 (s, 1H), 7.24 (d, J=7.6 Hz, 1H), 7.18 (t, J=7.6
Hz, 1H), 6.88 (t, J=7.6 Hz, 1H), 6.79 (d, J=7.6 Hz,
1H), 6.08 (s, 1H), 4.50 (dd, J=13.2, 4.8 Hz, 1H),
4.01-4.07 (m, 2H), 3.56-3.62 (m, 2H), 3.18-3.22
(m, 1H), 2.02-2.08 (m, 1H). HPLC separation condi-
tions: Chiralcel AD-H, solvent: Hexane/i-PrOH, V∶V
=85∶15, flow rate=1.0 mL/min, λ=254 nm. Reten-
tion time: tR(major)=78.22 min and tR(minor)=88.50
min.
3-Hydroxy-3-(4-oxotetrahydro-2H-thiopyran-3-yl)-
indolin-2-one (Table 6, Entry 4): [α]1D7 −14.7 (c 0.18,
1
(S)-tert-Butyl-3-hydroxy-2-oxo-3-((R)-2-oxocyclo-
CHCl3, 57% ee); H NMR (400 MHz, DMSO-d6) δ:
hexyl)indoline-1-carboxylate (Table 5, Entry 11): [α]1D7
10.28 (s, 1H), 7.25 (d, J=7.2 Hz, 1H), 7.17 (t, J=7.6
Hz, 1H), 6.86 (t, J=7.6 Hz, 1H), 6.79 (d, J=7.6 Hz,
1H), 6.08 (s, 1H), 3.47 (d, J=11.6 Hz, 1H), 3.19-3.31
(m, 2H), 2.90 (d, J=6.8 Hz, 2H), 2.42-2.65 (m, 2H);
13C NMR (100 MHz, DMSO-d6) δ: 208.1, 207.0, 178.5,
178.4, 143.7, 143.6, 130.7, 129.3, 129.2, 125.4, 123.5,
121.6, 121.5, 110.0, 109.6, 74.4, 73.5, 60.5, 45.2, 44.2,
30.9, 30.8, 29.4, 29.2; HRMS (ESI) calcd for
C13H13NO3S (M +H + ) 264.0689, found 264.0683.
HPLC separation conditions: Chiralcel AD-H, solvent:
Hexane/i-PrOH, V ∶V =85 ∶15, flow rate =1.0
mL/min, λ=254 nm. Retention time: tR(major)=46.13
min and tR(minor)=54.30 min.
1
+29.4 (c 0.12, CHCl3, −98% ee); H NMR (400 MHz,
CDCl3) δ: 7.89 (d, J=8.0 Hz, 1H), 7.35-7.39 (m, 2H),
7.17-7.28 (m, 1H), 4.98 (br s, 1H), 3.01 (dd, J=12.8,
4.8 Hz, 1H), 2.47 (d, J=15.2 Hz, 1H), 2.27-2.33 (m,
1H), 1.80-2.20 (m, 2H), 1.57-1.71 (m, 12H); 13C
NMR (100 MHz, CDCl3) δ: 213.5, 211.5, 175.4, 173.7,
149.1, 148.9, 140.6, 140.0, 130.2, 129.9, 127.7, 125.0,
124.7, 124.0, 115.3, 84.4, 56.4, 56.1, 42.6, 41.9, 28.1,
27.0, 26.8, 25.8, 24.4, 24.3; HRMS (ESI) calcd for
C19H23NO5Na (M+Na+) 368.1468, found 368.1460.
HPLC separation conditions: Chiralcel AD, solvent:
Hexane/i-PrOH, V ∶V =80 ∶20, flow rate =1.0
mL/min, λ=254 nm. Retention time: tR(anti,major)=
15.24 min and tR(anti,minor)=14.39 min.
tert-Butyl-3-(3-hydroxy-2-oxoindolin-3-yl)-4-oxo-
piperidine-1-carboxylate (Table 6, Entry 5): [α]1D7
1
(R)-3-Hydroxy-3-((S)-2-oxocyclohexyl)indolin-2-
+22.2 (c 0.11, CHCl3, 25% ee); H NMR (400 MHz,
one (Table 5, Entry 12):[23] [α]1D7 −25.3 (c 0.11, CHCl3,
DMSO-d6) δ: 10.30 (s, 1H), 7.25 (d, J=7.2 Hz, 1H),
7.15 (t, J=7.6 Hz, 1H), 6.87 (t, J=7.6 Hz, 1H), 6.76 (d,
J=8.0 Hz, 1H), 6.01 (s, 1H), 4.60 (br s, 1H), 4.11 (br s,
1H), 3.52 (br s, 1H), 3.04 (br s, 1H), 2.41-2.47 (m,
1H), 2.08-2.26 (m, 2H), 1.46 (s, 9H); 13C NMR (400
MHz, DMSO-d6) δ: 207.2, 206.6, 178.2, 154.3, 143.1,
129.4, 125.3, 123.8, 121.6, 110.1, 109.7, 79.8, 74.1,
73.2, 56.5, 55.4, 28.5, 28.4; HRMS (ESI) calcd for
C18H22N2O5 (M +H + ) 347.1602, found 347.1595.
HPLC separation conditions: Chiralcel AD-H, solvent:
1
94% ee); H NMR (400 MHz, DMSO-d6) δ: 10.20 (s,
1H), 7.22-7.14 (m, 2H), 6.87-6.77 (m, 2H), 5.83 (s,
1H), 3.07 (dd, J=13.2, 4.8 Hz, 1H), 2.59 (d, J=11.2
Hz, 1H), 2.27-2.36 (m, 1H), 1.45-2.04 (m, 6H).
HPLC separation conditions: Chiralcel OJ-H, hexane/
i-PrOH, V∶V=80∶20, flow rate=1.0 mL/min, λ=
254 nm; Retention time: tR(anti,major)=15.75 min and
tR(anti,minor)=19.56 min.
(R)-1-(3-Hydroxyindolin-3-yl)propan-2-one (Table 6,
Chin. J. Chem. 2014, 32, 417—428
© 2014 SIOC, CAS, Shanghai, & WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
427